» Articles » PMID: 28572674

Cytokine Profiling in the Sub-silicone Oil Fluid After Vitrectomy Surgeries for Refractory Retinal Diseases

Overview
Journal Sci Rep
Specialty Science
Date 2017 Jun 3
PMID 28572674
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Silicone oil (SO) is an intraocular surgical adjuvant that reduces the surgical complications in refractory retinal diseases, although membrane and cellular proliferation is often seen even in SO-filled eyes. We hypothesised that the fluid in the space between the SO and the retina, named the "sub-silicone oil fluid (SOF)", enhances these biological responses. We proposed a safe method for SOF extraction. We also analysed inflammatory cytokine expressions and SOF osmotic pressures from eyes with rhegmatogenous retinal detachment (RRD), proliferative diabetic retinopathy (PDR), proliferative vitreoretinopathy (PVR) and macular hole-associated retinal detachment (MHRD). Interleukin (IL)-10, IL-12p40, IL-6, monocyte chemotactic protein-1, and vascular endothelial growth factor (VEGF) in the SOF with PVR were significantly higher than in those with RRD or MHRD. Fibroblast growth factor-2, IL-10, IL-12p40, IL-8, VEGF, and transforming growth factor beta 1 levels in eyes with exacerbated PDR indicated a significantly higher expression than those with simple PDR. IL-6 and tumour necrosis factor alpha in eyes with exacerbated PVR demonstrated a significantly higher expression than in those with simple PVR. However, there was no difference in SOF osmotic pressure between group of each disease. These studies indicate that disease-specific SOF is a significant reflection of disease status.

Citing Articles

Vision loss associated with silicone oil endotamponade in vitreoretinal surgery - a review.

Januschowski K, Rickmann A, Smith J, Pastor-Idoate S, Pastor J Graefes Arch Clin Exp Ophthalmol. 2024; 262(11):3453-3463.

PMID: 38888804 DOI: 10.1007/s00417-024-06520-y.


Decrease in electrolyte after vitrectomy surgery may affect the results of forensic investigations using vitreous humor.

Ushida H, Suzumura A, Yamada K, Shimizu H, Suzuki A, Ishikawa Y BMC Ophthalmol. 2024; 24(1):219.

PMID: 38783230 PMC: 11118106. DOI: 10.1186/s12886-024-03445-2.


Corneal Astigmatism Alteration after Combined Silicone Oil Removal and Cataract Surgery with Intraocular Lens Implantation.

Ji Z, Su T, Li L, He T, Su Y J Ophthalmol. 2023; 2023:6175272.

PMID: 37415780 PMC: 10322570. DOI: 10.1155/2023/6175272.


Intravitreal Dexamethasone Implant at the Time of Silicon Oil Removal to Treat Persistent Macular Edema after Rhegmatogenous Retinal Detachment Repair.

Pignatelli F, Nacucchi A, Niro A, Gigliola S, Passidomo F, Donghia R J Clin Med. 2023; 12(4).

PMID: 36836233 PMC: 9962319. DOI: 10.3390/jcm12041697.


Dimethyl Fumarate Protects Retinal Pigment Epithelium from Blue Light-Induced Oxidative Damage via the Nrf2 Pathway.

Shimizu H, Takayama K, Yamada K, Suzumura A, Sato T, Nishio Y Antioxidants (Basel). 2023; 12(1).

PMID: 36670906 PMC: 9854498. DOI: 10.3390/antiox12010045.


References
1.
Takayama K, Kaneko H, Hwang S, Ye F, Higuchi A, Tsunekawa T . Increased Ocular Levels of MicroRNA-148a in Cases of Retinal Detachment Promote Epithelial-Mesenchymal Transition. Invest Ophthalmol Vis Sci. 2016; 57(6):2699-705. DOI: 10.1167/iovs.15-18660. View

2.
McGeachy M, Bak-Jensen K, Chen Y, Tato C, Blumenschein W, Mcclanahan T . TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol. 2007; 8(12):1390-7. DOI: 10.1038/ni1539. View

3.
MACHEMER R, BUETTNER H, Norton E, Parel J . Vitrectomy: a pars plana approach. Trans Am Acad Ophthalmol Otolaryngol. 1971; 75(4):813-20. View

4.
Abrams G, Azen S, Barr C, Lai M, Hutton W, Trese M . The incidence of corneal abnormalities in the Silicone Study. Silicone Study Report 7. Arch Ophthalmol. 1995; 113(6):764-9. DOI: 10.1001/archopht.1995.01100060090039. View

5.
Lewis H, Burke J, Abrams G, AABERG T . Perisilicone proliferation after vitrectomy for proliferative vitreoretinopathy. Ophthalmology. 1988; 95(5):583-91. DOI: 10.1016/s0161-6420(88)33136-2. View